XML 51 R39.htm IDEA: XBRL DOCUMENT
v3.21.1

Stockholders' Equity (Details Narrative) - USD ($) |  |  |  |  |  |  |  |  |  |  |  |  | 3 Months Ended |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Feb. 04, 2021 | Jan. 19, 2021 | Oct. 16, 2020 | Sep. 23, 2020 | Aug. 21, 2020 | Aug. 21, 2020 | Aug. 18, 2020 | Jul. 28, 2020 | Jul. 07, 2020 | Jun. 04, 2020 | May 15, 2020 | Apr. 03, 2020 | Feb. 20, 2020 | Mar. 31, 2021 | Mar. 31, 2020 | Dec. 31, 2020
Number of common stock shares issues |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock, par value |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 0.02 |  | $ .02
Preferred stock shares desginated |  |  |  |  |  |  |  |  |  |  |  |  |  | 47,000 |  | 47,000
Preferred stock liquidation per share |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,000 |  | $ 1,000
Preferred stock liquidation value |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 43,000,000 |  | $ 43,000,000
Stock compensation expense |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 15,000 | $ 90,000 |
Basic and diluted earnings per share |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 0.01 |  |
Number of common stock shares issues, value |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 61,068,000 | $ 4,054,000 |
Minimum [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic and diluted earnings per share |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 0.06 |
Series A Convertible Preferred Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Preferred stock liquidation value |  |  |  |  |  |  | $ 1,000 |  |  |  |  |  |  |  |  |
Impact BioMedical, Inc. [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of authorized shares of preferred stock |  |  |  |  |  |  | 47,000 |  |  |  |  |  |  |  |  |
Preferred stock par value |  |  |  |  |  |  | $ 0.02 |  |  |  |  |  |  |  |  |
Impact BioMedical, Inc. [Member] | Maximum [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equity ownership percentage |  |  |  |  | 100.00% | 100.00% |  |  |  |  |  |  |  |  |  |
Impact BioMedical, Inc. [Member] | Minimum [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equity ownership percentage |  |  |  |  | 63.60% | 63.60% |  |  |  |  |  |  |  |  |  |
Impact BioMedical, Inc. [Member] | Series A Convertible Preferred Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Preferred stock shares desginated |  |  |  |  |  |  | 47,000 |  |  |  |  |  |  |  |  |
Preferred stock liquidation per share |  |  |  |  |  |  | $ 1,000 |  |  |  |  |  |  |  |  |
Preferred stock liquidation value |  |  |  |  |  |  | $ 46,868,000 |  |  |  |  |  |  |  |  |
Equity ownership percentage |  |  |  |  |  |  | 19.99% |  |  |  |  |  |  |  |  |
Conversion price |  |  |  |  |  |  | $ 6.48 |  |  |  |  |  |  |  |  |
Conversion shares |  |  |  |  |  |  | 154.32 |  |  |  |  |  |  |  |  |
Global Biomedical Pte Ltd [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion shares |  |  | 4,293 |  |  |  |  |  |  |  |  |  |  |  |  |
Global Biomedical Pte Ltd [Member] | Series A Convertible Preferred Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion shares |  |  | 662,500 |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of common stock shares issues |  |  |  |  |  |  |  |  |  |  |  |  |  | 21,834,000 | 863,000 |
Number of common stock shares issues, value |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 436,000 | $ 18,000 |
Common Stock [Member] | Impact BioMedical, Inc. [Member] | Series A Convertible Preferred Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion shares |  |  |  |  |  |  | 7,232,670 |  |  |  |  |  |  |  |  |
Board of Directors Member] | Common Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares vested |  |  |  |  |  |  |  |  |  |  |  | 8,900 |  |  |  |
Share price |  |  |  |  |  |  |  |  |  |  |  | $ 6.60 |  |  |  |
Shares restricted stock issued |  |  |  |  |  |  |  |  |  |  |  | 5,800 |  |  |  |
Investor [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of common stock shares issues |  |  |  |  |  |  |  |  |  | 21,000 |  |  |  |  |  |
Number of common stock shares issues, value |  |  |  |  |  |  |  |  |  | $ 210,000 |  |  |  |  |  |
Chief Executive Officer and the Chairman of the Board [Member] | Common Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares vested |  |  |  | 20,000 |  |  |  |  |  |  |  |  |  |  |  |
Share price |  |  |  | $ 4.48 |  |  |  |  |  |  |  |  |  |  |  |
Underwriting Agreement [Member] | Underwriter Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Proceeds from net offering |  |  |  |  |  |  |  | $ 3,300,000 | $ 6,700,000 |  | $ 6,200,000 |  | $ 4,000,000 |  |  |
Underwriting Agreement [Member] | Underwriter Member] | Common Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of common stock shares issues |  |  |  |  |  |  |  | 453,333 | 1,028,800 |  | 769,230 |  | 740,741 |  |  |
Common stock, par value |  |  |  |  |  |  |  | $ 0.02 | $ 0.02 |  | $ 0.02 |  | $ 0.02 |  |  |
Share issued price per shares |  |  |  |  |  |  |  | $ 7.50 | $ 6.25 |  | $ 7.80 |  | 5.40 |  |  |
Pre-reverse stock split per share |  |  |  |  |  |  |  |  |  |  |  |  | $ 0.18 |  |  |
Underwriting Agreement [Member] | Underwriter Member] | Additional Shares [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of common stock shares issues |  |  |  |  |  |  |  | 38,533 | 154,320 |  | 115,384 |  | 111,111 |  |  |
Underwriting Agreement [Member] | Mr. Heng Fai Ambrose Chan [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Proceeds from net offering |  |  |  |  |  |  |  |  |  |  |  |  | $ 2,000,000 |  |  |
Share Exchange Agreement [Member] | Series A Convertible Preferred Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of common stock shares issues |  |  |  |  |  | 46,868 |  |  |  |  |  |  |  |  |  |
Share Exchange Agreement [Member] | Impact BioMedical, Inc. [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of common stock shares issues |  |  |  |  |  | 483,334 |  |  |  |  |  |  |  |  |  |
Common stock, par value |  |  |  |  | $ 0.02 | $ 0.02 |  |  |  |  |  |  |  |  |  |
Share issued price per shares |  |  |  |  | $ 6.48 | $ 6.48 |  |  |  |  |  |  |  |  |  |
Equity ownership percentage |  |  |  |  | 100.00% | 100.00% |  |  |  |  |  |  |  |  |  |
Share Exchange Agreement [Member] | Impact BioMedical, Inc. [Member] | Series A Convertible Preferred Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of common stock shares issues |  |  |  |  | 46,868 |  |  |  |  |  |  |  |  |  |  |
Share issued price per shares |  |  |  |  | $ 1,000 | $ 1,000 |  |  |  |  |  |  |  |  |  |
Number of common stock shares issues, value |  |  |  |  | $ 46,868,000 |  |  |  |  |  |  |  |  |  |  |
Jan. 2021 Underwriting Agreement [Member] | Maximum [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options to purchase additional shares | 1,847,901 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Jan. 2021 Underwriting Agreement [Member] | Aegis Capital Corp [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of common stock shares issues | 12,319,346 | 6,666,666 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock, par value | $ 0.02 | $ 0.02 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share issued price per shares | $ 2.80 | $ 3.60 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Proceeds from net offering | $ 361,400,000 | $ 24,900,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Jan. 2021 Underwriting Agreement [Member] | Aegis Capital Corp [Member] | Maximum [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options to purchase additional shares |  | 1,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |

X
- Definition Number of authorized shares of preferred stock. + References No definition available. + Details
Name: | DSS_NumberOfAuthorizedSharesOfPreferredStock
Namespace Prefix: | DSS_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Options to purchase additional shares. + References No definition available. + Details
Name: | DSS_OptionsToPurchaseAdditionalShares
Namespace Prefix: | DSS_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Pre-reverse stock split per share. + References No definition available. + Details
Name: | DSS_PrereverseStockSplitPerShare
Namespace Prefix: | DSS_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 14.F) -URI http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1)(i) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_AllocatedShareBasedCompensationExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Face amount or stated value per share of common stock. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockParOrStatedValuePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586 + Details
Name: | us-gaap_ConversionOfStockSharesConverted1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The price per share of the conversion feature embedded in the debt instrument. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 5 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 1B -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611 + Details
Name: | us-gaap_DebtInstrumentConvertibleConversionPrice1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 7 -URI http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256 + Details
Name: | us-gaap_EarningsPerShareBasicAndDiluted
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571 + Details
Name: | us-gaap_EquityMethodInvestmentOwnershipPercentage
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(d)) -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (h) -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644 + Details
Name: | us-gaap_PreferredStockLiquidationPreference
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Value of the difference between preference in liquidation and the par or stated values of the preferred shares. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(d)) -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (h) -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644 + Details
Name: | us-gaap_PreferredStockLiquidationPreferenceValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644 + Details
Name: | us-gaap_PreferredStockParOrStatedValuePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_PreferredStockSharesAuthorized
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The cash inflow associated with the amount received from entity's first offering of stock to the public. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585 + Details
Name: | us-gaap_ProceedsFromIssuanceInitialPublicOffering
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Price of a single share of a number of saleable stocks of a company. + References No definition available. + Details
Name: | us-gaap_SharePrice
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of options vested. + References No definition available. + Details
Name: | us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Per share or per unit amount of equity securities issued. + References No definition available. + Details
Name: | us-gaap_SharesIssuedPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of new stock issued during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_StockIssuedDuringPeriodValueNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=DSS_ImpactBioMedicalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=DSS_GlobalBioMedicalPteLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=DSS_SeriesAConvertiblePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=DSS_BoardOfDirectorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=us-gaap_InvestorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=DSS_ChiefExecutiveOfficerAndTheChairmanOfTheBoardMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=DSS_UnderwritingAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=DSS_UnderwriterMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=DSS_AdditionalSharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=DSS_MrHengFaiAmbroseChanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=DSS_ShareExchangeAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=DSS_JanuaryTwoThousandTwentyOneUnderwritingAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=DSS_AegisCapitalCorpMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |